GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 74 filers reported holding GALENA BIOPHARMA INC in Q3 2013. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $243,000 | -32.7% | 118,042 | 0.0% | 0.03% | -34.6% |
| Q2 2014 | $361,000 | +22.4% | 118,042 | 0.0% | 0.05% | +10.6% |
| Q1 2014 | $295,000 | -50.3% | 118,042 | -1.2% | 0.05% | -53.0% |
| Q4 2013 | $593,000 | +118.0% | 119,525 | +0.0% | 0.10% | +51.5% |
| Q3 2013 | $272,000 | +4.2% | 119,500 | +1.7% | 0.07% | -9.6% |
| Q2 2013 | $261,000 | – | 117,500 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 375,000 | $855,000 | 0.93% |
| HIGHLAND CAPITAL MANAGEMENT LP | 800,000 | $1,824,000 | 0.12% |
| Alyeska Investment Group, L.P. | 780,000 | $1,778,000 | 0.07% |
| KMS FINANCIAL SERVICES, INC | 119,500 | $272,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 539,150 | $1,229,000 | 0.04% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 25,100 | $57,000 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 349,400 | $793,000,000 | 0.02% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 12,000 | $27,000 | 0.02% |
| Diversified Trust Co | 40,000 | $91,000 | 0.01% |
| PITTENGER & ANDERSON INC | 18,000 | $41,000 | 0.01% |